Liang Lu,Bo Shen,Alexander Sokolsky,Xiaozhao Wang,Liangxing Wu,Wenqing Yao,Yingda Ye
申请号:
US16276701
公开号:
US20190269693A1
申请日:
2019.02.15
申请国别(地区):
US
年份:
2019
代理人:
摘要:
The present disclosure relates to bicyclic heterocycles of Formula (I′;), and pharmaceutical compositions of the same, that are inhibitors of the FGFR3 and/or FGFR4 enzyme and are useful in the treatment of FGFR-associated diseases.